Weekly nanoparticle albumin-bound paclitaxel in combination with cisplatin versus weekly solvent-based paclitaxel plus cisplatin as first-line therapy in Chinese patients with adva...

por Wang, Hai-ying, Yao, Zhi-hua, Tang, Hong, Zhao, Yan, Zhang, Xiao-san, Yao, Shu-na, Yang, Shu-jun, Liu, Yan-yan
Publicado 2016

Safety and Efficacy of Chemotherapy Combined with Anlotinib Plus Anlotinib Maintenance in Chinese Patients with Advanced/Metastatic Soft Tissue Sarcoma

por Wang, Hai-ying, Chu, Jun-feng, Zhang, Peng, Wang, Jia-qiang, Yan, Zheng, Yao, Shu-na, Yao, Zhi-hua, Liu, Yan-yan
Publicado 2020

Combining PD-1 Inhibitor Nivolumab with Radiotherapy Successfully Treated a Patient with Refractory Primary Mediastinal Large B-Cell Lymphoma: A Case Report and Literature Review

por Yan, Zheng, Yao, Zhi-Hua, Yao, Shu-Na, Xia, Qing-Xin, Wang, Hai-Ying, Chu, Jun-Feng, Song, Ming, Zhao, Shuang, Liu, Yan-Yan
Publicado 2020

A retrospective clinical study of comparing paclitaxel plus S-1 versus paclitaxel plus cisplatin as the first-line treatment for patients with advanced esophageal squamous cell car...

por Wang, Hai-ying, Yao, Zhi-hua, Tang, Hong, Zhao, Yan, Jin, Shui-ling, Zhou, Wen-ping, Yao, Shu-na, Yang, Shu-jun, Liu, Yan-yan, Luo, Su-xia
Publicado 2016